The blood-brain barrier in neuroAIDS

被引:73
作者
Banks, Wiliam A.
Ercal, Nuran
Otamis Price, Tulin
机构
[1] VAMC, GRECC, St Louis, MO 63106 USA
[2] St Louis Univ, Sch Med, Dept Internal Med, Div Geriatr, St Louis, MO USA
[3] Univ Missouri, Dept Chem, Rolla, MO 65401 USA
[4] Marmara Univ, Fac Pharm, Dept Biochem, TR-81010 Istanbul, Turkey
关键词
blood-brain barrier; transporter; virus; HIV-1; AIDS; cytokine;
D O I
10.2174/157016206777709447
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Nearly every aspect of blood-brain barrier (BBA) function is involved in or affected by HIV-1. The disruption of the BBB tends to be minimal and is not likely the mechanism by which infected immune cells and virus enter the brain. Instead, immune cells, virus and viral proteins likely activate brain endothelial cells and enable their own passage across the BBB by way of highly regulated processes such as diapedesis and adsorptive endocytosis. Viral proteins and cytokines can enter the CNS from the blood and provide a mechanism by which HIV-1 can affect CNS function independent of viral transport. Brain endothelial cells can also secrete neuroimmunoactive substances when stimulated by HIV-1, gp120, and Tat. Efflux systems such as p-glycoprotein transport anti-virals in the brain-to-blood direction, thus hampering effective accumulation of drug by the CNS. Overall, the BBB plays a major role in establishing and maintaining virus within the CNS and neuroAIDS.
引用
收藏
页码:259 / 266
页数:8
相关论文
共 117 条
[1]  
AGRAWAL R, 1999, NEUROCHEM RES, V24, P1507
[2]   The average-case complexity of determining the majority [J].
Alonso, L ;
Reingold, EM ;
Schott, R .
SIAM JOURNAL ON COMPUTING, 1997, 26 (01) :1-14
[3]   HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells [J].
András, IE ;
Pu, H ;
Deli, MA ;
Nath, A ;
Hennig, B ;
Toborek, M .
JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 74 (02) :255-265
[4]   SPECIFICITY VERSUS REDUNDANCY OF MELANOCORTINS IN NERVE REGENERATION [J].
ANTONAWICH, FJ ;
AZMITIA, EC ;
KRAMER, HK ;
STRAND, FL .
MODELS OF NEUROPEPTIDE ACTION, 1994, 739 :60-73
[5]   Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia [J].
Avison, MJ ;
Nath, A ;
Greene-Avison, R ;
Schmitt, FA ;
Bales, RA ;
Ethisham, A ;
Greenberg, RN ;
Berger, JR .
JOURNAL OF NEUROVIROLOGY, 2004, 10 (04) :223-232
[6]   Physiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders [J].
Banks, WA .
JOURNAL OF NEUROVIROLOGY, 1999, 5 (06) :538-555
[7]   Is obesity a disease of the blood-brain barrier? Physiological, pathological, and evolutionary considerations [J].
Banks, WA .
CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (10) :801-809
[8]  
Banks WA, 1998, J CELL SCI, V111, P533
[9]   Permeability of the blood-brain barrier to HIV-1 Tat [J].
Banks, WA ;
Robinson, SM ;
Nath, A .
EXPERIMENTAL NEUROLOGY, 2005, 193 (01) :218-227
[10]   Evidence that the species barrier of human immunodeficiency virus-1 does not extend to uptake by the blood-brain barrier: Comparison of mouse and human brain microvessels [J].
Banks, WA ;
Kumar, VB ;
Franko, MW ;
Bess, JW ;
Arthur, LO .
LIFE SCIENCES, 2005, 77 (19) :2361-2368